DETECTION OF ALUMINUM AND IRON IN BONE IN PATIENTS WITH CHRONIC-RENAL-FAILURE - A SURVEY

被引:0
|
作者
VANDEVYVER, FL [1 ]
DHAESE, PC [1 ]
DEBROE, ME [1 ]
机构
[1] UNIV INSTELLING ANTWERP,NEPHROL HOCHDRUCK ABT,B-2610 WILRIJK,BELGIUM
关键词
AL-DEPOSITION IN BONE; ELECTROTHERMAL ATOMIC ABSORPTION SPECTROMETRY (ETAAS); ALUMINON STAINING; LASER MICROPROBE MASS ANALYSIS (LAMMA); SECONDARY ION MASS X-RAY SPECTROMETRY (S/MS); RISK OF ADYNAMIC BONE DISEASE IN IRON OVERLOAD;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Deposition of aluminum (Al) occurs frequently in chronic renal failure. While the degree of deposition shows variations, the bone Al-content is always exceeding the normal range. Electrothermal atomic absorption spectrometry (ETAAS) proved as the preferred method of determination of Al in biological specimens. The histochemical staining of Al on the trabecular surface is a >>conditio sine qua non<< to detect Al, when an Al-induced osteopathy is suspected. Furthermore microanalytic examinations can be used to prove the histochemical findings: The laser microprobe mass analysis (LAMMA) is a useful method to identify the elements histochemically detected. Other microanalytic methods like electroprobe X-ray microanalysis (EPXMA) and the secondary ion mass spectrometry (SIMS) succeeded in ultrastructural localisation of Al in tissues. The LAMMA-technique used in undecalcified bone samples is able to verify the histochemical Aluminon staining. The investigation to elucidate the relationship between iron accumulation and the appearance of renal osteopathy proved the increased risk of adynamic bone disease in dialysis patients with iron overload.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 50 条
  • [21] AMOUNT OF BONE AND BONE REMODELING IN NORMAL SUBJECTS AND IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    ANDRESEN, J
    NIELSEN, HE
    ACTA RADIOLOGICA-DIAGNOSIS, 1986, 27 (03): : 341 - 347
  • [22] IRON SUPPLEMENTS AND HEMOSIDEROSIS IN CHRONIC-RENAL-FAILURE
    SWAMY, AP
    KOTHARI, T
    LEE, JCK
    CESTERO, RVM
    MANGLA, JC
    DIALYSIS & TRANSPLANTATION, 1980, 9 (11) : 1073 - &
  • [23] MINERALIZATION OF BONE TISSUE IN CHRONIC-RENAL-FAILURE
    WARDYN, K
    DZIEDZICGOCLAWSKA, A
    STACHOWICZ, S
    STASIAK, L
    OSTROWSKI, K
    SICINSKI, A
    ACTA MEDICA POLONA, 1985, 26 (3-4) : 123 - 129
  • [24] BONE-LESIONS IN CHRONIC-RENAL-FAILURE
    RINGE, JD
    MEDIZINISCHE KLINIK, 1982, 77 (05) : 147 - 149
  • [25] HEMATOLOGIC PARAMETERS AND IRON STORES IN PATIENTS ON HEMODIALYSIS FOR CHRONIC-RENAL-FAILURE
    NUWAYRISALTI, N
    JABRE, F
    DAOUK, M
    SAAB, G
    SALEM, Z
    CLINICAL NEPHROLOGY, 1992, 38 (02) : 101 - 104
  • [26] DIAGNOSIS AND MANAGEMENT OF BONE DISORDERS IN CHRONIC-RENAL-FAILURE AND DIALYZED PATIENTS
    TZAMALOUKAS, AH
    MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (04) : 961 - 974
  • [27] ENDOTHELIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    NEMECEK, K
    BARTOVA, V
    JACHYMOVA, M
    HORKY, K
    RENAL FAILURE, 1995, 17 (05) : 559 - 563
  • [28] ATRACURIUM IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    RUSSO, R
    RAVAGNAN, R
    BUZZETTI, V
    FAVINI, P
    BRITISH JOURNAL OF ANAESTHESIA, 1986, 58 : S63 - S63
  • [29] HYPERCHLOREMIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    WAKABAYASHI, Y
    SAKAMOTO, H
    MISHINA, T
    MARUMO, F
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 149 (02): : 145 - 150
  • [30] TUBERCULOSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    TEMMESFELDWOLLBRUCK, B
    ECKHARDT, T
    GARRECHT, M
    MEDIZINISCHE WELT, 1993, 44 (02): : 86 - 89